Recent studies have reported prominent KIFC1 expression in various cancers, including breast, prostate, ovarian, and non-small cell lung cancers, making it a promising target for cancer therapy owing to its redundancy in normal somatic cells[16,17]. Here, KIFC1 is linked to cancer.